|dc.contributor.advisor||Hauqe, Shamim Ehsanul||
|dc.contributor.author||Zoha, Md. Samauz||
|dc.description||This internship report is submitted in a partial fulfillment of the requirements for the degree of Master of Business Administration, 2015.||en_US
|dc.description||Cataloged from PDF version of Internship report.||
|dc.description||Includes bibliographical references (page 29).||
|dc.description.abstract||Opsonin Pharma Limited is a private limited company. Opsonin is committed to improve its
position continuously as a Leading Pharmaceutical company in Bangladesh and strengthen its
global presence. Opsonin creates value for its customers and other stakeholders by providing
highest quality health care solutions through appropriate application and development of
resources and processes. . Its main market is in Southeast Asia Africa Eastern Asia. It is
involved with manufacturing, distributing and wholesaling. Main products of Opsonin Pharma
includes Antihistamines, vitamins and minerals, NSAIDS, Antispasmodics, Corticosteroids,
Laxatives, Expectorants, Analgesics, Antiprotozoals, and Anti-diarrhoeals.
Opsonin Pharma Limited is renowned for its outstanding product quality, world class
manufacturing facilities, product development capabilities and unparalleled services.
Environment, health and safety are an integral part of Opsonin’s corporate responsibility. As a
pharmaceutical company, they improve health not only through the production and distribution
of medicine to our consumers, but also through our commitment to protect the environment,
health and safety of our co workers and the communities where they operate.
My internship report on Opsonin Pharma Limited is to study performance evaluation practice
of the company finding lacking and corrective actions.
In this consideration I have presented the existing practice. Base on Key result area
performance of employees is evaluated by the departmental heads. Performance evaluation
form is circulated at the end of the year. Form is filled up both the apprise and appraiser. There
is a scoring where A (90 and above) stands for outstanding performance. All functional head
forward performance appraisal form to HRD. Then HRD summaries the evaluation and make a
promotion and upgradation committee. The committee decides the employees entitled for
promotion and upgradation. In the performance evaluation of Opsonin Pharma Ltd. I have the
following findings: Though Opsonin Pharma Limited has well-structured policies and procedures for
performance evaluation but there are some lacking in the area of setting KRA (Key
result area) and properly evaluating employees by the departmental heads.
Though there is a provision for weightage in key performance areas but it is not being
implemented due to lack of coordination. Say for example, commercial departments
tasks is delayed by non-cooperation of other functional areas. As a result they are not
interested to set fix any time frame base on which performance can be evaluated.
Within the fixed time frame performance evaluation is not done due to lack of
coordination from other departments that should be improved.
Opsonin Pharma has no formal (written) vision, mission and goals and Organizational
Objectives that is a serious issue to be defined.
In this regard I have the following recommendation:
For evaluating performance properly Opsonin Pharma Should take initiative to redesign job
structure as well as Job description, Specification. Opsonin should introduce vision, mission,
goals and organization objectives of the organization. After setting organizational objectives
we should introduce departmental objectives which will help us to define Key result area. After
setting KRA weight should be given and then proper monitoring of an incumbents
responsibility should be done through the departmental Heads. Departmental Head should
properly introduce with the performance evaluation, setting KPI aligned with the
|dc.description.statementofresponsibility||Md. Samauz Zoha||
|dc.rights||BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.||
|dc.subject||Opsonin Pharma Limited||en_US
|dc.title||Performance evaluation at Opsonin Pharma Limited||en_US
|dc.contributor.department||BRAC Business School, BRAC University||
|dc.description.degree||M. Business Administration||